Diabetic Foot Ulcer Treatment Market Worth USD 11.05 Billion at 5.9% CAGR; Rising Adoption of Novel Wound Care Devices to Propel Growth: Fortune Business Insights™

The global “diabetic foot ulcer treatment market” size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes followed by a foot ulcer. A diabetic foot ulcer is an open wound occurring in the sole of the feet of a diabetic person and requires immediate pressure, off-loading, infection control, and vasculature to heal. As per a recent report by Fortune Business Insights, titled, “Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Covid-19 Impact Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027,” the value of the market was USD 7.03 billion in 2019 and is anticipated to reach USD 11.05 billion by the end of 2027. The market is presumed to rise at a CAGR of 5.9% during the forecast period, 2020 to 2027.

To control the spread of the novel coronavirus worldwide, most nations have acquired social distancing and quarantine policies to attenuate the impact of this pandemic. Several businesses are adopting machine learning tools for analyzing the effects of these measures.

We, at Fortune Business Insights, are offering insightful data in the form of special reports on the market affected by the COVID-19 pandemic. These reports will come in handy when taking strategic decisions on investment and return revenue in the coming years.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948

Some of the Key Players of the DFU Treatment Market Include:

  • 3M (Minnesota, United States)
  • Braun Melsungen AG (Melsungen, Germany)
  • Smith & Nephew (London, U.K.)
  • Tissue Regenix (West Yorkshire, U.S.)
  • ConvaTec Group Plc(England, U.K.)
  • Cardinal Health (Ohio, United States)
  • Coloplast Corp (Humlebaek, Denmark)
  • Integra LifeSciences Corporation (New Jersey, United States)
  • Mölnlycke Health Care AB (Gothenburg, Sweden)
  • Other players

The Report Answers the Following Questions:

  • What is the nature of the market and how fierce is the competition?
  • Who are the major players of the diabetic foot ulcer market and what are their prime strategies?
  • Which is the leading segment of this market and why?
  • How will COVID-19 impact the market for diabetic foot ulcer treatment?

Request a Sample Copy of the Research Report

Drivers & Restraints-

Increasing Adoption of Extracellular Matrix Proteins to Propel Growth

A rise in the geriatric population and their vulnerability to various chronic diseases stand as the key drivers for promoting the diabetic foot ulcer treatment market growth. This, coupled with the increasing adoption of novel wound care devices, is aiding in the expansion of the market. Additionally, a rise in the availability of treatment option for diabetic foot ulcer is likely to augment the market growth in the coming years.

On the contrary, factors such as high cost of the advanced wound care therapies and devices and the lack of reimbursement policies may cause hindrance to the market growth in the coming years. Despite this, the advent and the increasing popularity of extracellular matrix proteins, bioengineered skin substitutes, and others are likely to create lucrative growth opportunities for the market for DFU treatment in the coming years.

Related Reports:

Recombinant Vaccines Market Rise

Recombinant Vaccines Market CAGR Value

Recombinant Vaccines Market Covid Effect

Recombinant Vaccines Market Condition

Recombinant Vaccines Market Search Analysis

Recombinant Vaccines Market Growth Analysis

Recombinant Vaccines Market Revenue

Recombinant Vaccines Market Manufacturers

Recombinant Vaccines Market Drivers

Recombinant Vaccines Market Research Methodology

Recombinant Vaccines Market Future Growth

Recombinant Vaccines Market Devlopment Strategy

Recombinant Vaccines Market Industry

Recombinant Vaccines Market Overview

Recombinant Vaccines Market Segments

Recombinant Vaccines Market Competitive Landscape

Recombinant Vaccines Market Demand

Recombinant Vaccines Market Key Players

Recombinant Vaccines Market Business Opportunities

Recombinant Vaccines Market Analysis

Recombinant Vaccines Market Growth

Recombinant Vaccines Market Trends

Recombinant Vaccines Market Share

Recombinant Vaccines Market Size

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

LinkedIn | Twitter | Blogs